359 related articles for article (PubMed ID: 31805809)
1. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
[No Abstract] [Full Text] [Related]
2. Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes.
Nowak C; Carlsson AC; Östgren CJ; Nyström FH; Alam M; Feldreich T; Sundström J; Carrero JJ; Leppert J; Hedberg P; Henriksen E; Cordeiro AC; Giedraitis V; Lind L; Ingelsson E; Fall T; Ärnlöv J
Diabetologia; 2018 Aug; 61(8):1748-1757. PubMed ID: 29796748
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
Di Marco M; Scilletta S; Miano N; Marrano N; Natalicchio A; Giorgino F; Di Mauro S; Filippello A; Scamporrino A; Tribulato P; Bosco G; Di Giacomo Barbagallo F; Scicali R; Milluzzo A; Ballirò T; Frittitta L; Castellino P; Purrello F; Piro S; Di Pino A
Cardiovasc Diabetol; 2023 Dec; 22(1):344. PubMed ID: 38093293
[TBL] [Abstract][Full Text] [Related]
4. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
5. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
[TBL] [Abstract][Full Text] [Related]
6. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
Jin Q; Lau ESH; Luk AO; Tam CHT; Ozaki R; Lim CKP; Wu H; Chow EYK; Kong APS; Lee HM; Fan B; Ng ACW; Jiang G; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Cheung EYN; Kam G; Lau IT; Li JK; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Yu W; Tsui SKW; Tomlinson B; Huang Y; Lan HY; Szeto CC; So WY; Jenkins AJ; Fung E; Muilwijk M; Blom MT; 't Hart LM; Chan JCN; Ma RCW;
Diabetologia; 2024 May; 67(5):837-849. PubMed ID: 38413437
[TBL] [Abstract][Full Text] [Related]
7. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
[TBL] [Abstract][Full Text] [Related]
8. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
[TBL] [Abstract][Full Text] [Related]
9. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
[TBL] [Abstract][Full Text] [Related]
10. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
11. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
[TBL] [Abstract][Full Text] [Related]
12. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
13. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
[TBL] [Abstract][Full Text] [Related]
14. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Salles GC; Ferreira MT; Salles GF
Diabetologia; 2018 Feb; 61(2):455-465. PubMed ID: 29063128
[TBL] [Abstract][Full Text] [Related]
15. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
16. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
[TBL] [Abstract][Full Text] [Related]
17. Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD).
Hamon SM; Griffin TP; Islam MN; Wall D; Griffin MD; O'Shea PM
Clin Chem Lab Med; 2019 Mar; 57(4):510-520. PubMed ID: 30218600
[TBL] [Abstract][Full Text] [Related]
18. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
[TBL] [Abstract][Full Text] [Related]
19. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
20. Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria.
Carlsson AC; Sundström J; Carrero JJ; Gustafsson S; Stenemo M; Larsson A; Lind L; Ärnlöv J
Eur J Prev Cardiol; 2017 Mar; 24(4):340-348. PubMed ID: 27794105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
